Retatrutide Prices in 2026: What It Actually Costs (and Why One Supplier Is 55% Cheaper)

Retatrutide is the compound people are searching for most on this site right now — and also the one where we're currently losing almost all of that traffic, because the price and availability questions people actually have weren't answered anywhere on the site until now. Here's what it actually costs.

What It Actually Costs Right Now

Snapshot of every supplier we track, by dose:

• 20mg — 24 Hour Peptides: £99.99 · Evora: £155 — a 55% spread for the identical dose
• 40mg — Evora: £205 (only one supplier currently tracked at this size)
• 60mg — Evora: £235 (only one supplier currently tracked at this size)

24 Hour Peptides currently runs a COMPOUNDSEARCH discount code; Evora runs PEPGIRL10. Applying either narrows or widens the gap above depending on which supplier and dose you're comparing — worth doing the actual math for your specific order rather than assuming the sticker price is the final price.

Only the 20mg size has more than one supplier tracked yet, which is exactly why it's the one with a real price war and the other two aren't — less competition at a given dose means less pressure on price, not a signal that the 40mg or 60mg price is unfair.

Why Retatrutide Specifically Is Having a Moment

Retatrutide is a triple-receptor agonist — it activates GIP, GLP-1, and glucagon receptors, which is the mechanistic difference from tirzepatide (Mounjaro/Zepbound), a dual GIP/GLP-1 agonist that's already FDA-approved. That third receptor is the reason for the outsized interest: in the TRIUMPH-1 trial, the 12mg group averaged 28.3% weight loss at 80 weeks, with 45.3% of that group losing 30% or more of body weight — numbers ahead of the approved GLP-1/GIP drugs on the market today. We covered the full trial breakdown separately: Retatrutide's Trial Data Is Genuinely Remarkable.

It is not FDA-approved. Eli Lilly holds the primary efficacy dataset and a filing is expected before the end of 2026, but a filing isn't an approval — retatrutide remains investigational and is sold for research use only, not as an approved prescription weight-loss drug. That gap between "genuinely impressive trial data" and "not yet approved" is exactly why availability and pricing are messier than an established drug's would be, and exactly why comparing before buying matters more here than it would for something already standardized.

Before You Buy

Prices above are a snapshot — they move, and this post won't get updated every time they do. The live retatrutide comparison is the actual current number for every size and supplier we track, not this post. Check that page directly, apply whichever discount code applies to the supplier you're ordering from, and confirm the dose you need is the one actually in stock before assuming the price you saw here still holds.